HRP20110045T1 - Sinteza acilaminoalkenilen amida korisnih kao antagonista supstance p - Google Patents

Sinteza acilaminoalkenilen amida korisnih kao antagonista supstance p Download PDF

Info

Publication number
HRP20110045T1
HRP20110045T1 HR20110045T HRP20110045T HRP20110045T1 HR P20110045 T1 HRP20110045 T1 HR P20110045T1 HR 20110045 T HR20110045 T HR 20110045T HR P20110045 T HRP20110045 T HR P20110045T HR P20110045 T1 HRP20110045 T1 HR P20110045T1
Authority
HR
Croatia
Prior art keywords
formula
compound
protecting group
boc protecting
image
Prior art date
Application number
HR20110045T
Other languages
English (en)
Croatian (hr)
Inventor
Portmann Robert
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0607532A external-priority patent/GB0607532D0/en
Priority claimed from GB0610244A external-priority patent/GB0610244D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HRP20110045T1 publication Critical patent/HRP20110045T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20110045T 2006-04-13 2007-04-11 Sinteza acilaminoalkenilen amida korisnih kao antagonista supstance p HRP20110045T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0607532A GB0607532D0 (en) 2006-04-13 2006-04-13 Organic compounds
GB0610244A GB0610244D0 (en) 2006-05-23 2006-05-23 Organic compounds
PCT/EP2007/003213 WO2007118651A1 (en) 2006-04-13 2007-04-11 Synthesis of acylaminoalkenylene amides useful as substance p antagonists

Publications (1)

Publication Number Publication Date
HRP20110045T1 true HRP20110045T1 (hr) 2011-02-28

Family

ID=38324102

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110045T HRP20110045T1 (hr) 2006-04-13 2007-04-11 Sinteza acilaminoalkenilen amida korisnih kao antagonista supstance p

Country Status (28)

Country Link
US (2) US8008479B2 (da)
EP (1) EP2010498B1 (da)
JP (1) JP5208917B2 (da)
KR (1) KR20080108291A (da)
AR (1) AR060506A1 (da)
AT (1) ATE486853T1 (da)
AU (1) AU2007237482B2 (da)
CA (1) CA2645362C (da)
CL (1) CL2007001040A1 (da)
CY (1) CY1111294T1 (da)
DE (1) DE602007010269D1 (da)
DK (1) DK2010498T3 (da)
EC (1) ECSP088820A (da)
GT (1) GT200800209A (da)
HR (1) HRP20110045T1 (da)
JO (1) JO2630B1 (da)
MA (1) MA30394B1 (da)
MX (1) MX2008013117A (da)
MY (1) MY145069A (da)
NO (1) NO20084783L (da)
NZ (1) NZ571142A (da)
PE (1) PE20071223A1 (da)
PL (1) PL2010498T3 (da)
PT (1) PT2010498E (da)
RU (1) RU2433122C2 (da)
SI (1) SI2010498T1 (da)
TW (1) TW200815358A (da)
WO (1) WO2007118651A1 (da)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005295927B2 (en) 2004-10-12 2012-02-02 Fmc Biopolymer As Self-gelling alginate systems and uses thereof
CN101273024A (zh) 2005-07-29 2008-09-24 康瑟特制药公司 新颖苯并[d][1,3]-二氧杂环戊烯衍生物
US8796267B2 (en) 2006-10-23 2014-08-05 Concert Pharmaceuticals, Inc. Oxazolidinone derivatives and methods of use
US8080549B2 (en) 2007-01-12 2011-12-20 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
US8071596B2 (en) 2007-01-12 2011-12-06 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
EP2125717B1 (en) 2007-02-26 2013-07-03 Concert Pharmaceuticals Inc. Deuterated derivatives of silodosin as alpha ia-adrenoreceptor antagonists
JP2010520291A (ja) 2007-03-07 2010-06-10 コンサート ファーマシューティカルズ インコーポレイテッド 抗狭心症化合物としての重水素化ピペラジン誘導体
CA2681628C (en) 2007-03-16 2016-10-18 Concert Pharmaceuticals, Inc. Inhibitors of cholesterol ester transfer protein
WO2008128166A1 (en) 2007-04-13 2008-10-23 Concert Pharmaceuticals Inc. Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
ES2401914T3 (es) 2007-04-25 2013-04-25 Concert Pharmaceuticals Inc. Análogos de Cilostazol
US8349817B2 (en) 2007-04-25 2013-01-08 Concert Pharmaceuticals, Inc. Analogues of cilostazol
MX385316B (es) 2007-05-01 2025-03-18 Concert Pharmaceuticals Inc Compuestos de morfinano.
AU2008247818B2 (en) 2007-05-01 2011-10-20 Sun Pharmaceutical Industries, Inc. Morphinan compounds
WO2008141021A1 (en) 2007-05-08 2008-11-20 Concert Pharmaceuticals, Inc. Deuterated derivatives of tetrahydrotriazolopyrazine compounds and their use as dpp-iv inhibitors
KR20120029480A (ko) 2007-06-12 2012-03-26 콘서트 파마슈티컬즈, 인크. 아자펩티드 유도체
CA2702317A1 (en) 2007-07-09 2009-01-15 Concert Pharmaceuticals, Inc. Novel pyrimidinecarboxamide derivatives
US7985750B2 (en) 2007-08-14 2011-07-26 Concert Pharmaceuticals, Inc. Substituted oxazolidinone derivatives
US8809521B2 (en) 2007-08-28 2014-08-19 Fmc Biopolymer As Delayed self-gelling alginate systems and uses thereof
AU2008299931B2 (en) 2007-09-12 2013-01-10 Concert Pharmaceuticals, Inc. Deuterated 4 -oxoquinoline derivatives for the treatment of HIV infection
JP5647519B2 (ja) 2007-09-13 2014-12-24 コンサート ファーマシューティカルズ インコーポレイテッド 重水素化カテコールおよびベンゾ［ｄ］［１，３］ジオキソールおよびその誘導体の合成
EP2212298B1 (en) 2007-10-18 2013-03-27 Concert Pharmaceuticals Inc. Deuterated etravirine
US8592487B2 (en) 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
WO2009079637A1 (en) 2007-12-18 2009-06-25 Concert Pharmaceuticals, Inc. Tetrahydroisoquinoline derivatives
US8609673B2 (en) 2008-01-22 2013-12-17 Concert Pharmaceuticals, Inc. Vandetanib derivatives
WO2009094216A1 (en) 2008-01-22 2009-07-30 Concert Pharmaceuticals Inc. Derivatives of gefitinib
KR20100121527A (ko) 2008-02-29 2010-11-17 콘서트 파마슈티컬즈, 인크. 치환된 잔틴 유도체
WO2009128947A1 (en) 2008-04-17 2009-10-22 Concert Pharmaceuticals, Inc. Piperazine derivatives
WO2009154754A2 (en) 2008-06-17 2009-12-23 Concert Pharmaceuticals, Inc. Synthesis of deuterated morpholine derivatives
ES2451542T3 (es) 2008-08-29 2014-03-27 Concert Pharmaceuticals Inc. Derivados de triazolo-piridazina sustituidos
EP2334621A1 (en) 2008-09-16 2011-06-22 Concert Pharmaceuticals, Inc. Deuterated 2-amino-3-hydroxypropanoic acid derivatives
MX361542B (es) 2008-09-19 2018-12-10 Concert Pharmaceuticals Inc Compuestos de morfinan.
US9045453B2 (en) 2008-11-14 2015-06-02 Concert Pharmaceuticals, Inc. Substituted dioxopiperidinyl phthalimide derivatives
WO2010097381A1 (en) * 2009-02-24 2010-09-02 Novartis Ag Uses of nk receptor antagonists
US8263601B2 (en) 2009-02-27 2012-09-11 Concert Pharmaceuticals, Inc. Deuterium substituted xanthine derivatives
US8952016B2 (en) 2009-02-27 2015-02-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
DE102009001446A1 (de) 2009-03-10 2010-09-23 Evonik Rohmax Additives Gmbh Verwendung von Kammpolymeren als Antifatigue-Additive
BRPI1009199A2 (pt) 2009-03-17 2016-03-08 Concert Pharmaceuticals Inc compostos de pirazinoisoquinolina
WO2010108103A1 (en) * 2009-03-19 2010-09-23 Concert Pharmaceuticals, Inc. Azepan-2-one derivatives
DK2421808T3 (da) 2009-04-23 2013-11-04 Concert Pharmaceuticals Inc 4-Hydroxysmørsyreanaloger
US8410082B2 (en) 2009-05-22 2013-04-02 Concert Pharmaceuticals, Inc. Fluorinated diaryl urea derivatives
EA021019B1 (ru) 2009-06-18 2015-03-31 Концерт Фармасьютикалс, Инк. Дейтерированные производные изоиндолин-1,3-диона
US8501738B2 (en) 2009-06-23 2013-08-06 Concert Pharmaceuticals, Inc. Substituted triazolo-pyridazine derivatives
US8557815B2 (en) 2009-08-14 2013-10-15 Concert Pharmaceuticals, Inc. Substituted triazolophthalazine derivatives
WO2011028820A1 (en) 2009-09-02 2011-03-10 Concert Pharmaceuticals, Inc. Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
WO2011047315A1 (en) 2009-10-15 2011-04-21 Concert Pharmaceuticals, Inc. Subsitituted benzimidazoles
WO2011063001A1 (en) 2009-11-18 2011-05-26 Concert Pharmaceuticals, Inc. Niacin prodrugs and deuterated versions thereof
DE102010001040A1 (de) 2010-01-20 2011-07-21 Evonik RohMax Additives GmbH, 64293 (Meth)acrylat-Polymere zur Verbesserung des Viskositätsindexes
US8575361B2 (en) 2010-03-02 2013-11-05 Concert Pharmaceuticals Inc. Tetrahydronaphthalene derivatives
US8513434B2 (en) 2010-03-02 2013-08-20 Concert Pharmaceuticals Inc. Tetrahydronaphthalene derivatives
US9226801B2 (en) * 2010-03-08 2016-01-05 Ibur, Llc Custom linkable imaging and multifunctional tray
US8575221B2 (en) 2010-03-17 2013-11-05 Concert Pharmaceuticals, Inc. Derivatives of dimethylcurcumin
US9107922B2 (en) 2010-07-16 2015-08-18 Concert Pharmaceuticals, Inc. Pyrimidinecarboxamide derivatives
US9085788B2 (en) 2010-09-01 2015-07-21 Concert Pharmaceuticals, Inc. Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
WO2012031073A1 (en) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
KR101976218B1 (ko) 2011-02-14 2019-05-07 콘서트 파마슈티컬즈, 인크. 4-히드록시부티르산 중수소화 유사체
US9145390B2 (en) 2011-03-03 2015-09-29 Concert Pharmaceuticals, Inc. Derivatives of pyrazole-substituted amino-heteroaryl compounds
US8889687B2 (en) 2011-03-04 2014-11-18 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
HUE047354T2 (hu) 2011-05-18 2020-04-28 Vertex Pharmaceuticals Europe Ltd Ivacaftor deuterizált származékai
KR20150002779A (ko) 2012-04-13 2015-01-07 콘서트 파마슈티컬즈, 인크. 치환된 크산틴 유도체
US9249093B2 (en) 2012-04-20 2016-02-02 Concert Pharmaceuticals, Inc. Deuterated rigosertib
DK3882249T3 (da) 2012-06-15 2025-08-25 Sun Pharmaceutical Ind Inc Deutererede derivater af ruxolitinib
US9181190B2 (en) 2012-07-04 2015-11-10 Concert Pharmaceuticals, Inc. Deuterated vercirnon
EP2885267B1 (en) 2012-07-12 2018-09-05 Concert Pharmaceuticals, Inc. Deuterated idebenone
BR112015001839A2 (pt) 2012-07-30 2017-07-04 Concert Pharmaceuticals Inc ibrutinibe deuterado
EP3492472A1 (en) 2012-08-17 2019-06-05 Concert Pharmaceuticals Inc. Deuterated baricitinib with improved metabolic stability as jak1 and jak2 kinase inhibitor for treating e.g. rheumatoid arthritis
EP2922838B1 (en) 2012-10-22 2018-03-14 Concert Pharmaceuticals Inc. Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione} .
EP2943489B1 (en) 2013-01-09 2018-04-11 Concert Pharmaceuticals Inc. Deuterated momelotinib
CA2906396A1 (en) 2013-03-15 2014-09-25 Concert Pharmaceuticals Inc. Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
US8906951B1 (en) 2013-06-24 2014-12-09 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
US9198898B2 (en) 2013-06-24 2015-12-01 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
US9676790B2 (en) 2013-08-30 2017-06-13 Concert Pharmaceuticals, Inc. Substituted thienotriazolodiazapines
EP3105232B1 (en) 2014-02-10 2019-08-28 Concert Pharmaceuticals Inc. Substituted triazolobenzodiazepines
US10160778B2 (en) 2014-10-27 2018-12-25 Concert Pharmaceuticals, Inc. Pyrimidine phosphonic acid esters
HK1249893A1 (zh) 2015-03-31 2018-11-16 Vertex Pharmaceuticals (Europe) Limited 氘代vx-661
US10683305B2 (en) 2015-04-27 2020-06-16 Concert Pharmaceuticals, Inc. Deuterated OTX-015
EP3352758A4 (en) 2015-09-25 2018-08-01 Vertex Pharmaceuticals (Europe) Limited Deuterated cftr potentiators
US11267777B2 (en) 2015-11-19 2022-03-08 Concert Pharmaceuticals, Inc. Deuterated EPI-743
EP3416629A4 (en) 2016-02-16 2019-08-07 CoNCERT Pharmaceuticals, Inc. DEUTERATED GFT-505
AU2018371784B2 (en) 2017-11-22 2024-10-17 Sun Pharmaceutical Industries, Inc. Deuterated analogs of D-serine and uses thereof
CN117924170A (zh) 2017-12-01 2024-04-26 弗特克斯药品有限公司 用于制备囊性纤维化跨膜传导调节因子的调节剂的方法
US12065395B2 (en) 2019-04-03 2024-08-20 Sun Pharmaceutical Industries, Inc. Processes for the preparation of deuterated D-serine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3506714B2 (ja) * 1995-02-22 2004-03-15 ノバルティス・アクチエンゲゼルシャフト １−アリール−２−アシルアミノ−エタン化合物およびニューロキニン特にニューロキニン１アンタゴニストとしてのそれらの用途
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB0010958D0 (en) * 2000-05-05 2000-06-28 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
AR060506A1 (es) 2008-06-25
NZ571142A (en) 2011-02-25
HK1125640A1 (en) 2009-08-14
KR20080108291A (ko) 2008-12-12
RU2433122C2 (ru) 2011-11-10
DK2010498T3 (da) 2011-02-14
US20090137797A1 (en) 2009-05-28
AU2007237482A1 (en) 2007-10-25
CA2645362C (en) 2013-07-16
MA30394B1 (fr) 2009-05-04
MX2008013117A (es) 2008-10-21
DE602007010269D1 (de) 2010-12-16
CY1111294T1 (el) 2015-08-05
WO2007118651A1 (en) 2007-10-25
US20110282053A1 (en) 2011-11-17
EP2010498B1 (en) 2010-11-03
CL2007001040A1 (es) 2008-03-14
NO20084783L (no) 2008-11-12
MY145069A (en) 2011-12-15
RU2008145102A (ru) 2010-05-27
JO2630B1 (en) 2012-06-17
TW200815358A (en) 2008-04-01
US8008479B2 (en) 2011-08-30
PT2010498E (pt) 2011-02-08
PE20071223A1 (es) 2008-01-22
PL2010498T3 (pl) 2011-04-29
ECSP088820A (es) 2008-11-27
JP2009533369A (ja) 2009-09-17
GT200800209A (es) 2008-12-15
SI2010498T1 (sl) 2011-03-31
AU2007237482B2 (en) 2011-03-17
CA2645362A1 (en) 2007-10-25
JP5208917B2 (ja) 2013-06-12
EP2010498A1 (en) 2009-01-07
ATE486853T1 (de) 2010-11-15

Similar Documents

Publication Publication Date Title
RU2008145102A (ru) Синтез ациламиноалкениленамидов, пригодных в качестве антагонистов вещества р
JP2009533369A5 (da)
GEP20074138B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
HRP20090151T3 (en) Indozolone derivatives as 11b-hsd1 inhibitors
HUP0401538A2 (hu) Új, helyettesített aminometilcsoportot tartalmazó N-(arilszulfonil)-béta-aminosav-származékok, előállításukra alkalmas eljárás és a vegyületeket tartalmazó gyógyászati készítmények
ATE374765T1 (de) Substituierte heterocyclische amide
SK109095A3 (en) Method of production of trans-6-£2-(substituted-pyrol-1-yl)alkyl| pyran-2-one intermediates of this method and pharmaceutical agents
EA200900817A1 (ru) Способ получения фторметилзамещённых гетероциклических соединений
GEP20074135B (en) Process for the synthesis of (is)-4,5-dimethoxy-1-(methylaminomethyl)- benzocyclobutane and addition salts thereof, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
CA2401832A1 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
BRPI0507005A (pt) compostos, composições farmacêuticas, uso de um composto, e, método de preparo de uma composição farmacêutica
MX2009005440A (es) Procedimiento para la produccion de derivados de fenilalanina que tienen estructuras de base de quinazolinodiona e intermediarios para la produccion.
WO2004020430A3 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
NO20052476L (no) 2-alkyl-(2-amino-3-aryl-propionyl)-piperazinderivater og beslektede forbindelser som melanokortinreseptorligander for behandlingen av obesitet.
MY136686A (en) Salt forms of 3-(4-bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide and method of production
HRP20030566B1 (en) Improved process for carbapenem synthesis
ATE429429T1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
HRP20090474T1 (hr) Postupak i intermedijeri za sintezu kaspofungina
NO20063681L (no) Aryloksyalkylkarbamattype derivater, fremgangsmate for fremstilling derav og anvendelse av derivatene i terapeutiske midler
TNSN07006A1 (en) Novel heterocyclic compounds
TW200606167A (en) Method for preparation of 1-oxachephalosporin-7 α-methoxy-3-cloromethyl derivative
CA2461060A1 (en) Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
NO20071253L (no) Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.
JP2011510026A5 (da)
ATE550326T1 (de) Als modulatoren von hdl einsetzbare verbindungen